Replies to post #72018 on NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

If we had not reached the 1st IA by 2016 then L is a winner by my modelling. --- Branco

Here's the other side of that story ... if we are just now hitting 1st IA, then this might be indicative that patients are "living longer" ... but it would indicate that we are at 60% of events. And thus have 40% yet to go before the trial reaches its conclusion. And ... NWBO would perhaps not be able to continue to find the funding in order to get us to the finish line. NWBO would go bankrupt and/or the shares could go below a dime and below a penny. So DCVax-L might be doing well, but in the meantime the company goes down the tubes.

[flipper44]

Thanks Branko. That sounds about right....within a margin of error (of course).